J. B. Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM.NS
Sector
Location
Market Cap
USD 3.06 B
Share Price
USD 19.57
Avg Daily Volume
306,933
Change (1 day)
-0.20%
Change (1 year)
-16.46%
Change (YTD)
-9.16%
J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2025: 21.97%
J. B. Chemicals & Pharmaceuticals Limited EBIT Margin is 21.97% for the year ending March 31, 2025, a -4.74% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2024 was 23.06%, a 21.84% change year over year.
-
J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2023 was 18.93%, a -9.82% change year over year.
-
J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2022 was 20.99%, a -30.24% change year over year.
-
J. B. Chemicals & Pharmaceuticals Limited EBIT Margin for the year ending March 31, 2021 was 30.09%, a 48.97% change year over year.
StockViz
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 131.15
MRK.DE
+1.91
1.48%
WuXi AppTec Co., Ltd.
USD 13.74
2359.HK
+0.05
0.37%
Bayer AG
USD 31.66
BAYN.DE
+0.64
2.07%
Teva Pharmaceutical Industries Limited
USD 17.46
TEVA.TA
+0.54
3.21%
Lupin Limited
USD 22.36
LUPIN.NS
-0.38
-1.69%
Aurobindo Pharma Limited
USD 12.35
AUROPHARMA.NS
+0.03
0.23%
Pharmaron Beijing Co., Ltd.
USD 2.84
3759.HK
-0.03
-0.97%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 15.19
002821.SZ
+0.08
0.55%
Siegfried Holding AG
USD 108.43
SFZN.SW
+0.82
0.77%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.96
600521.SS
+0.06
2.03%
Hybio Pharmaceutical Co., Ltd.
USD 3.63
300199.SZ
+0.17
5.04%
Syngene International Limited
USD 7.61
SYNGENE.NS
+0.08
1.01%
Piramal Pharma Limited
USD 2.17
PPLPHARMA.NS
-0.03
-1.36%
Yifan Pharmaceutical Co., Ltd.
USD 2.21
002019.SZ
+0.08
3.88%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
USD 2.61
603456.SS
+0.03
1.04%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 131.15
MRK.DE
+1.91
1.48%
WuXi AppTec Co., Ltd.
USD 13.74
2359.HK
+0.05
0.37%
Bayer AG
USD 31.66
BAYN.DE
+0.64
2.07%
Teva Pharmaceutical Industries Limited
USD 17.46
TEVA.TA
+0.54
3.21%
Lupin Limited
USD 22.36
LUPIN.NS
-0.38
-1.69%
Aurobindo Pharma Limited
USD 12.35
AUROPHARMA.NS
+0.03
0.23%
Pharmaron Beijing Co., Ltd.
USD 2.84
3759.HK
-0.03
-0.97%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 15.19
002821.SZ
+0.08
0.55%
Siegfried Holding AG
USD 108.43
SFZN.SW
+0.82
0.77%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.96
600521.SS
+0.06
2.03%
Hybio Pharmaceutical Co., Ltd.
USD 3.63
300199.SZ
+0.17
5.04%
Syngene International Limited
USD 7.61
SYNGENE.NS
+0.08
1.01%
Piramal Pharma Limited
USD 2.17
PPLPHARMA.NS
-0.03
-1.36%
Yifan Pharmaceutical Co., Ltd.
USD 2.21
002019.SZ
+0.08
3.88%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
USD 2.61
603456.SS
+0.03
1.04%